Emergent Biosolutions Inc (EBS) Key Ratios

$5.91

up-down-arrow $-0.03 (-0.51%)

As on 28-Aug-2026 13:42EDT

Market cap

info icon

$247 Mln

Revenue (TTM)

info icon

$770 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.7

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 50.10 66.29 -9.56 -10.46 -14.73
EBIT -- -- -64.62 31.47 -33.23
Net Profit -2,750.00 -1,401.67 -226.74 19.72 -190.01
EPS -3,001.65 -1,477.33 -243.02 19.73 -191.40
Book Value -- -- 11.96 -28.95 -17.81
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info -0.632.027.9519.13-5.00
Net Margin info ---3.37-22.96----
Return on equity info -32.63-19.53-40.9310.46-33.67
Return on Capital info -14.93-8.75--4.67-14.29
Return on Assets info -12.82-7.57-12.703.88-11.86
Debt to Equity (x) info ----1.701.091.40
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
--
4.67
-14.29
-35.18
-7.99
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-40.93

Lower than Peers by 59.90

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
-40.93
10.46
-33.67
-74.67
-14.11
Peer Median
18.97
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-12.70

Lower than Peers by 15.56

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
-12.70
3.88
-11.86
-30.48
-6.91
Peer Median
2.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

7.95

Lower than Peers by 7.87

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
7.95
19.13
-5.00
-16.02
-9.78
Peer Median
15.82
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-22.96

Lower than Peers by 31.19

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
-22.96
7.08
-18.26
-72.48
-19.14
Peer Median
8.23
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

-9.56

Lower than Peers by 17.61

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
-9.56
-0.29
-0.01
-0.06
-0.37
Peer Median
8.05
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-64.62

Lower than Peers by 72.89

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
-64.62
372.22
68.95
-53.80
-128.32
Peer Median
8.26
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-226.74

Lower than Peers by 234.47

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
-226.74
127.60
74.94
-259.40
-196.40
Peer Median
7.73
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-243.02

Lower than Peers by 253.41

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
-243.02
1.29
0.76
-2.46
-2.03
Peer Median
10.39
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-33.12

Lower than Peers by 38.00

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
-33.12
--
--
--
--
Peer Median
4.87
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

1.70

Higher than Peers by 1.11

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
1.70
1.09
1.40
1.32
1.03
Peer Median
0.59
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
--
--
0.01
0.64
0.69
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

5.42

Higher than Peers by 3.77

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
5.42
5.01
3.69
1.04
0.98
Peer Median
1.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

2.95

Higher than Peers by 1.75

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
2.95
2.41
1.77
0.54
0.70
Peer Median
1.20
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-1.87

Lower than Peers by 6.64

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
-1.87
2.40
-0.74
-1.91
-2.93
Peer Median
4.77
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

24.67

Higher than Peers by 3.40

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
24.67
11.33
14.80
18.20
14.25
Peer Median
21.27
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.55

Higher than Peers by 0.15

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
0.55
0.55
0.65
0.42
0.36
Peer Median
0.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
--
58.68
60.46
60.95
71.60
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
--
304.96
175.08
180.06
196.99
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
--
54.23
47.31
57.15
65.85
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
--
309.41
188.23
183.86
202.73
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
--
12.31
-2.72
-0.16
-2.79
Peer Median
37.31
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.73

Lower than Peers by 7.02

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
0.73
1.24
1.07
0.19
0.42
Peer Median
7.75
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
--
--
--
--
--
Peer Median
0.50
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

5.24

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
5.24
4.22
20.50
-18.39
87.46
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

247

Lower than Peers by 2,344

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Emergent Biosolutions Inc (EBS)
247
--
--
--
--
Peer Median
2,591
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...